Glow LifeTech (9DO) Stock Price & Analysis
9DO Stock Chart & Stats
- Day’s Range
- EUR 0.02 - EUR 0.02
- 52-Week Range
- EUR 0.00 - EUR 0.06
- Previous Close
- EUR 0.02
- Volume
- N/A
- Average Volume (3M)
- 383
- Market Cap
- EUR 4.93M
- Enterprise Value
- EUR 7.10M
- Total Cash (Recent Filing)
- EUR 1.60M
- Total Debt (Recent Filing)
- EUR 34.51K
- Price to Earnings (P/E)
- ―
- Beta
- 0.08
- Next Earnings
- Dec 01, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth
Revenue has increased substantially across the reported periods, indicating improving commercial traction and market adoption. If this expansion continues, greater scale could support operating leverage, broaden the company’s revenue base, and improve its ability to fund product development over the next several quarters.
Narrowing Losses
The material reduction in net losses shows that the business is moving toward greater financial efficiency as revenue scales. Although profitability has not been achieved, sustained improvement in loss levels would preserve capital, reduce funding pressure, and increase the prospect of reaching break-even.
Low Financial Leverage
Very low debt relative to equity limits fixed financing obligations and reduces balance-sheet risk during the company’s commercialization phase. Improved equity also suggests a stronger capital position than in 2023, giving management more flexibility to support operations and pursue growth without heavy leverage.
Bears Say
Persistent Negative Margins
The company remains structurally unprofitable, with both net and operating margins below zero. This indicates that current revenue is not yet sufficient to cover operating costs, leaving results sensitive to spending levels and execution. Durable margin improvement is necessary before growth can consistently translate into earnings.
Negative Cash Generation
Negative operating and free cash flow means the business is still consuming cash rather than funding itself through operations. While the burn has improved from earlier years, continued cash usage can constrain investment capacity and may require additional financing before the company reaches sustainable break-even.
Negative Returns On Equity
A negative return on equity shows that shareholder capital is not yet producing positive returns, despite the improvement in the equity position. This weakens the quality of current earnings power and highlights that management must improve profitability and capital productivity for the balance sheet to create durable shareholder value.
Glow LifeTech News
9DO FAQ
What was Glow LifeTech’s price range in the past 12 months?
What is Glow LifeTech’s market cap?
When is Glow LifeTech’s upcoming earnings report date?
How were Glow LifeTech’s earnings last quarter?
Is Glow LifeTech overvalued?
Does Glow LifeTech pay dividends?
What is Glow LifeTech’s EPS estimate?
How many shares outstanding does Glow LifeTech have?
What happened to Glow LifeTech’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Glow LifeTech?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Glow LifeTech
Glow Lifetech Corp. is a biotechnology enterprise based in North America, dedicated to the development and marketing of nutraceutical and cannabinoid-derived products. The company is actively commercializing two core technologies: MyCell Enhanced technology, which facilitates the optimal delivery of nutrients for both nutraceuticals and cannabis, and a Cannabis Smart Consumption System, designed to help users and patients store, track, manage, and consume cannabis products effectively. Glow Lifetech possesses exclusive rights throughout North America for the production, sale, and distribution of a specific micellization technology, applicable to cannabis and hemp-derived ingredients, curcumin, Vitamin K, and iron. A key aspect of their operations involves the advanced processing of ingredients, converting certain vitamins, nutraceuticals, and cannabis extracts into micellized forms. This process significantly boosts the bioavailability of fat-soluble compounds, ensuring near 100% absorption into the body and enhancing their compatibility with water. The company, founded in 2018, is headquartered in Toronto, Canada.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Roberto Paolo Carducci
- Employees
- 5
- Website
- www.glowlifetech.com
- Address
- 65 International Boulevard, Etobicoke, ON, M9W 6L9, CA
Glow LifeTech (9DO) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 2 | 5 |
| Technical Analysis | 3 | 2 | 5 |
| Moving Averages | 12 | 0 | 0 |







